Gynaecologist and infertility specialist Dr Deniss Sõritsa is the only doctor in South-Estonia offering OSCAR screening with the preeclampsia screening (11-14 weeks of pregnancy) to detect the complications during pregnancy. During the OSCAR screening the risk of preeclampsia is being assessed.
Preeclampsia (PE) is an important cause of maternal and perinatal mortality and morbidity.
The risk of adverse outcome is much higher when the disease is severe and of early onset requiring delivery before 37 weeks’ gestation (preterm PE) than at term.
A major challenge in modern obstetrics is early identification of pregnancies at high-risk of preterm PE and undertaking of the necessary measures to improve placentation and reduce the prevalence of the disease.
ASPRE trial about prevention of preeclampsia:
The ASPRE trial concluded that treatment with low-dose aspirin in women at high risk for preterm PE reduces substantially the incidence of this disease.
For a pregnant woman it means that via help of OSCAR screening with the preeclampsia screening it is possible already during first trimester of pregnancy to identify the pregnancies at high-risk of preterm PE and to prevent the preeclampsia with aspirin among the risk group.
To read more about the study please click: Prevention of preeclampsia